New drug aims to prevent dangerous clots after knee surgery
NCT ID NCT07140523
First seen Jan 17, 2026 · Last updated May 06, 2026 · Updated 15 times
Summary
This study tests a new drug called SRSD107 to prevent blood clots in adults aged 60-80 having knee replacement surgery. About 450 participants will receive either SRSD107 or a standard blood thinner, enoxaparin, for up to 28 days before surgery. The goal is to see which dose works best and is safe.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENOUS THROMBOEMBOLISM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Nové Město na Moravě
RECRUITINGNové Město na Moravě, Czechia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.